Skip to main content
Top
Published in: Advances in Therapy 4/2009

01-04-2009 | Review

Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy

Authors: Giuseppe Marazzi, Otavio Gebara, Cristiana Vitale, Giuseppe Caminiti, Mauricio Wajngarten, Maurizio Volterrani, José A. F. Ramires, Giuseppe Rosano, Massimo Fini

Published in: Advances in Therapy | Issue 4/2009

Login to get access
Metadata
Title
Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy
Authors
Giuseppe Marazzi
Otavio Gebara
Cristiana Vitale
Giuseppe Caminiti
Mauricio Wajngarten
Maurizio Volterrani
José A. F. Ramires
Giuseppe Rosano
Massimo Fini
Publication date
01-04-2009
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 4/2009
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-009-0024-7

Other articles of this Issue 4/2009

Advances in Therapy 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine